Period:
Draw Mode:
| Volume | 148,916 |
|
|||||
| News | - | ||||||
| Day High | 2.075 | Low High |
|||||
| Day Low | 1.93 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Kodiak Sciences Inc | KOD | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.075 | -3.68% | 1.965 | 13:52:05 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.06 | 1.93 | 2.075 | 2.04 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,410 | 148,916 | $ 1.98 | $ 294,348 | - | 1.9125 - 9.80 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:52:05 | 400 | $ 1.965 | USD |
Kodiak Sciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 103.07M | 52.45M | - | 0 | -333.82M | -6.36 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Kodiak Sciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KOD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.10 | 2.16 | 1.9125 | 2.02 | 434,366 | -0.135 | -6.43% |
| 1 Month | 2.28 | 2.47 | 1.9125 | 2.16 | 568,937 | -0.315 | -13.82% |
| 3 Months | 7.02 | 7.8373 | 1.9125 | 3.58 | 1,148,083 | -5.06 | -72.01% |
| 6 Months | 4.90 | 9.80 | 1.9125 | 4.81 | 868,129 | -2.94 | -59.9% |
| 1 Year | 7.74 | 9.80 | 1.9125 | 5.36 | 583,586 | -5.78 | -74.61% |
| 3 Years | 59.50 | 171.21 | 1.9125 | 30.93 | 603,037 | -57.54 | -96.7% |
| 5 Years | 10.00 | 171.21 | 1.9125 | 33.73 | 470,572 | -8.04 | -80.35% |
Kodiak Sciences Description
| Kodiak Sciences Inc is is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. |